Controlling the family-wise error rate in multi-arm, multi-stage trials
Controlling the family-wise error rate in multi-arm, multi-stage trials
Background and aims: Multi-arm, multi-stage trials have recently gained attention as a means to improve the efficiency of the clinical trials process. Many designs have been proposed, but few explicitly consider the inherent issue of multiplicity and the associated type I error rate inflation. It is our aim to propose …